> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Lonza Swiss Facility Gets FDA-483
- URL: https://www.fdaweb.com/lonza-swiss-facility-gets-fda-483/
- Published: 2024-07-15T12:00:00.000Z
- Updated: 2026-09-14T14:35:24.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157351

A 3/2023 inspection at a Lonza Visp, Switzerland manufacturing facility has resulted in a one-item [Form FDA-483](https://www.fda.gov/media/180072/download?ref=fdaweb.com). The inspection found that the company’s laboratory records do not include complete data derived from all tests, examinations and assays necessary to assure compliance with established specifications and standards, according to the inspection report. It also found that Lonza failed to report exact values for “total aerobic microbial count” in water trend test result, it says.